BenzingaSeptember 21, 2026 at 5:48 AM NYLast Month
Oppenheimer Maintains Outperform on Boston Scientific, Lowers Price Target to $65
Oppenheimer analyst Suraj Kalia maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $85 to $65.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
